Fred Alger Management, LLC Guardant Health, Inc. Transaction History

Fred Alger Management, LLC

$22.4 Billion
Q3 2025

A detailed history of Fred Alger Management, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Fred Alger Management, LLC holds 638,487 shares of GH stock, worth $60.3 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

638,487

Previous 373,679 70.87%

Holding current value

$60.3 Million

Previous $19.4 Million 105.14%

% of portfolio

0.18%

Previous 0.1%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$40.98 - $67.42 $10.9 Million - $17.9 Million	264,808 Added 70.87%	638,487 $39.9 Million
Q2 2025 Aug 14, 2025	SELL	$37.05 - $52.04 $3.11 Million - $4.37 Million	-83,938 Reduced 18.34%	373,679 $19.4 Million
Q1 2025 May 15, 2025	BUY	$31.77 - $49.94 $9.6 Million - $15.1 Million	302,145 Added 194.34%	457,617 $19.5 Million
Q4 2024 Feb 14, 2025	BUY	$20.2 - $38.11 $868 - $1,638	43 Added 0.03%	155,472 $4.75 Million
Q3 2024 Nov 14, 2024	SELL	$22.3 - $36.29 $959,769 - $1.56 Million	-43,039 Reduced 21.69%	155,429 $3.56 Million

Q2 2024 Aug 14, 2024	BUY	$16.07 - $31.84 $1.03 Million - $2.04 Million	64,206 Added 47.82%	198,468 $5.73 Million
Q1 2024 May 15, 2024	BUY	$17.13 - $26.91 $1.42 Million - $2.23 Million	82,946 Added 161.64%	134,262 $2.77 Million
Q4 2023 Feb 14, 2024	SELL	$21.58 - $29.5 $10,962 - $14,986	-508 Reduced 0.98%	51,316 $1.39 Million
Q3 2023 Nov 14, 2023	BUY	$25.8 - $39.97 $1.34 Million - $2.07 Million	51,824 New	51,824 $1.54 Million
Q1 2023 May 15, 2023	SELL	$22.92 - $33.76 $10,955 - $16,137	-478 Reduced 4.56%	10,000 $234,000
Q4 2022 Feb 14, 2023	SELL	$25.44 - $59.78 $2.63 Million - $6.17 Million	-103,268 Reduced 90.79%	10,478 $285,000
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $133,206 - $186,111	-3,051 Reduced 2.61%	113,746 $6.12 Million
Q2 2022 Aug 15, 2022	SELL	$28.82 - $77.35 $7.29 Million - $19.6 Million	-252,878 Reduced 68.41%	116,797 $4.71 Million
Q1 2022 May 16, 2022	SELL	$48.25 - $100.49 $66.6 Million - $139 Million	-1,380,516 Reduced 78.88%	369,675 $24.5 Million
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $81 Million - $110 Million	-913,431 Reduced 34.29%	1,750,191 $175 Million
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $13.9 Million - $18.7 Million	-141,172 Reduced 5.03%	2,663,622 $333 Million
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $18.4 Million - $27.7 Million	167,305 Added 6.34%	2,804,794 $348 Million
Q1 2021 May 17, 2021	BUY	$127.04 - $179.1 $72 Million - $102 Million	567,042 Added 27.39%	2,637,489 $403 Million
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $12.7 Million - $17.2 Million	126,880 Added 6.53%	2,070,447 $267 Million
Q3 2020 Nov 13, 2020	SELL	$80.32 - $111.8 $11.9 Million - $16.5 Million	-147,548 Reduced 7.06%	1,943,567 $217 Million
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $54 Million - $87 Million	892,602 Added 74.48%	2,091,115 $170 Million
Q1 2020 May 15, 2020	SELL	$59.04 - $88.81 $8.04 Million - $12.1 Million	-136,247 Reduced 10.21%	1,198,513 $83.4 Million
Q4 2019 Feb 14, 2020	BUY	$59.49 - $82.78 $64.1 Million - $89.2 Million	1,077,513 Added 418.86%	1,334,760 $104 Million
Q3 2019 Nov 14, 2019	SELL	$62.59 - $110.3 $2.57 Million - $4.53 Million	-41,062 Reduced 13.76%	257,247 $16.4 Million
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $12.5 Million - $17.8 Million	195,148 Added 189.17%	298,309 $25.8 Million
Q1 2019 May 14, 2019	BUY	$34.3 - $97.98 $1.17 Million - $3.33 Million	34,032 Added 49.23%	103,161 $7.91 Million
Q4 2018 Feb 14, 2019	BUY	$29.2 - $46.1 $2.02 Million - $3.19 Million	69,129 New	69,129 $2.6 Million

Others Institutions Holding GH

# of Institutions

450

Shares Held

125M

Call Options Held

2.18M

Put Options Held

2.69M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $9.65B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account

Fred Alger Management, LLC Guardant Health, Inc. Transaction History